La Roche-Blanche, France

Fabrice Anizon

This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, Les Laboratoires Servier, Les Laboratories Servier. Active years: 2003-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fabrice Anizon. Retrieved from https://idiyas.com/inventor/fabrice-anizon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 33.3

 

Average Co-Inventor Count = 7.6

ph-index = 2

Forward Citations = 11(Granted Patents)


Location History:

  • Ennezat, FR (2003 - 2006)
  • La Roche-Blanche, FR (2013)

Company Filing History:


Years Active: 2003-2013

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Fabrice Anizon: Innovator in Pharmaceutical Chemistry

Introduction

Fabrice Anizon is a notable inventor based in La Roche-Blanche, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on pyrrolo[2,3-a]carbazole derivatives.

Latest Patents

Fabrice Anizon holds three patents, with his latest inventions focusing on the development of pyrrolo[2,3-a]carbazole derivatives. These compounds are designed to serve as PIM kinase inhibitors, showcasing their potential application in the pharmaceutical industry. Another notable patent involves [3,4-a:3,4-c]carbazole compounds, which are selected from a specific formula that highlights their unique chemical properties.

Career Highlights

Throughout his career, Fabrice has worked with esteemed organizations such as Les Laboratories Servier. His experience in these companies has allowed him to refine his expertise in pharmaceutical research and development.

Collaborations

Fabrice Anizon has collaborated with professionals like Michelle Prudhomme and Alain Pierre, contributing to various projects that enhance the field of pharmaceutical innovation.

Conclusion

Fabrice Anizon's work exemplifies the intersection of innovation and pharmaceutical science. His patents and collaborations reflect a commitment to advancing medical research and developing new therapeutic options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…